Medtronic PLC | Income Statement

Fiscal year is May-April. All values USD Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
17,005
20,261
28,833
29,710
29,953
30,557
Cost of Goods Sold (COGS) incl. D&A
4,604
6,932
10,972
11,234
10,810
10,828
Gross Income
12,401
13,329
17,861
18,476
19,143
19,729
SG&A Expense
7,324
8,544
11,693
11,904
12,190
12,630
EBIT
4,690
4,755
-
-
6,953
7,099
Unusual Expense
1,000
663
799
866
791
794
Non Operating Income/Expense
123
315
177
376
224
121
Interest Expense
379
677
1,223
1,094
1,108
987
Pretax Income
3,705
3,486
4,336
4,602
5,675
5,197
Income Tax
640
811
798
578
2,580
547
Consolidated Net Income
3,065
2,675
3,538
4,024
3,095
4,650
Net Income
3,065
2,675
3,538
4,028
3,104
4,631
Net Income After Extraordinaries
3,065
2,675
3,538
4,028
3,104
4,631
Net Income Available to Common
3,065
2,675
3,538
4,028
3,104
4,631
EPS (Basic)
3.02
2.41
2.48
2.89
2.27
3.41
Basic Shares Outstanding
1,002
1,096
1,410
1,379
1,357
1,346
EPS (Diluted)
3.02
2.41
2.48
2.89
2.27
3.41
Diluted Shares Outstanding
1,014
1,109
1,426
1,391
1,368
1,358
EBITDA
5,540
6,061
8,924
9,489
9,597
9,758
Other Operating Expense
387
30
64
-
-
-
Non-Operating Interest Income
271
386
431
366
397
-
Minority Interest Expense
-
-
-
4
9
19

About Medtronic

View Profile
Address
20 On Hatch
Dublin Dublin 2
Ireland
Employees -
Website http://www.medtronic.com
Updated 07/08/2019
Medtronic Plc is a medical technology company, which develop, manufacture, distribute, and sell device-based medical therapies and services. It also provides services to the hospitals, physicians, clinicians, and patients. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group.